STAT4 and systemic lupus erythematosus: In addition, the activation of interferon (IFN) type I pathways is commonly observed in patients with pSS, SLE, and RA, and the genetic variants of its downstream molecules, such as STAT4, are associated with the risk of these diseases [10].